Kura Oncology, Inc.KURANASDAQ
Loading
Operating Cash Flow Growth Under PressureDecelerating
Percentile Rank7
Studio
Year-over-Year Change

Year-over-year operating cash flow growth rate

Latest
-147.69%
↓ 752% vs avg
Percentile
P7
Near historical low
Streak
1 yr
Consecutive declineDecelerating
Average
-17.32%
Historical baseline
PeriodValue
2025-147.69%
2024207.61%
2023-13.41%
2022-5.27%
2021-49.72%
2020-27.52%
2019-12.55%
2018-71.07%
2017-12.20%
2016-41.42%